Primary source: EMA - Regulatory and procedural guidelines RSS
The EudraVigilance access policy and web report data elements have been officially outlined, impacting user access and reporting accuracy.
The guidelines are essential for regulatory compliance and effective signal management, ensuring stakeholders utilize the EudraVigilance database effectively.
Stakeholders must familiarize themselves with the new data elements for Individual Case Safety Reports (ICSRs) as per the revised EudraVigilance access policy effective immediately.
Regulatory Intelligence Lead
Review in the next regulatory intelligence cycle.
Stakeholders must familiarize themselves with the new data elements for Individual Case Safety Reports (ICSRs) as per the revised EudraVigilance access policy effective immediately.
The document serves as a user manual for accessing the EudraVigilance database regarding suspected adverse reactions related to medicines, providing essential information for compliance and signal management.
What changed: The EudraVigilance access policy and web report data elements have been officially outlined, impacting user access and reporting accuracy.
Why it matters: The guidelines are essential for regulatory compliance and effective signal management, ensuring stakeholders utilize the EudraVigilance database effectively.
Practical implication: Stakeholders must familiarize themselves with the new data elements for Individual Case Safety Reports (ICSRs) as per the revised EudraVigilance access policy effective immediately.
Published from the regulator source ingestion pipeline after PV impact triage.
Users must carefully inspect the VentStar Resus Neo hoses for damages as per the product's Instructions for Use (IFU) and discard any hoses showing signs of cracks or detachments before use.
Immediate quarantine and destruction of all affected lots are mandated. Affected inventory must be checked, and customers must be notified if products have been resold or transferred.
Healthcare providers must implement the new administration protocol for Zanvastro, which is an injection every three months, and monitor for common side effects such as vomiting, back pain, and signs of aseptic meningitis.
Ensure that all labeling and safety information reflects the updated product name 'Prasugrel Viatris' instead of 'Prasugrel Mylan'.
